-
FDA approves new Dr. Reddy's injectable drug
HYDERABAD, India — The Food and Drug Administration has approved an injected drug for the bone marrow disorder myelodysplastic syndrome made by Dr. Reddy's Labs, the company said Tuesday.
Dr. Reddy's announced the approval of azacitidine injection in the 100-mg-per-vial strength. The drug is a generic version of Celgene's Vidaza, and Dr. Reddy's plans to launch the product in the near future.
Vidaza had sales of about $378.5 million during the 12-month period ended in July, according to IMS Health.
-
At least 23,000 die from antibiotic-resistant infections each year, CDC finds
ATLANTA — Antibiotic-resistant bacteria sicken more than 2 million people per year and kill at least 23,000, according to a new study by the Centers for Disease Control and Prevention.
And the costs go beyond human health and life. According to a study by Tufts University, direct healthcare costs and costs to society for lost productivity from the infections could be as high as $55 billion per year.